Holen Sie sich die Stockscreener-App
3.61
15.46%
-0.66
Handel nachbörslich:
3.77
0.16
+4.43%
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
FY2026 EPS Forecast for Edesa Biotech Decreased by Analyst - Defense World
Point72 group (NASDAQ: EDSA) reports 600,000 shares, 7.2% stake - Stock Titan
Velan Capital details Edesa Biotech (NASDAQ: EDSA) 9.99% stake - Stock Titan
Nijhawan group boosts Edesa Biotech (EDSA) stake to 19.99% in 13D/A - Stock Titan
Edesa Biotech (NASDAQ: EDSA) CEO adds 50,571 shares in open-market buys - Stock Titan
[Form 4] Edesa Biotech, Inc. Insider Trading Activity - Stock Titan
EDSA: Strengthened Phase 3 ARDS Data Shows Significant Reduction in 28-Day Mortality - Yahoo Finance
Edesa Biotech Advances with Promising Phase 3 Outcomes - StocksToTrade
Edesa Biotech’s Paridiprubart Phase 3 Success Drives Optimism - timothysykes.com
Edesa Biotech’s Strategic Advances Boost Stock Outlook - StocksToTrade
Edesa Biotech Surpasses Expectations with Promising Phase 3 Data - timothysykes.com
EDSA Technical Analysis & ETF Price Forecast - Intellectia AI
Why Is Edesa Biotech, Inc. (EDSA) Stock Up Today? - Meyka
Why Did EDSA Stock Rally More Than 70% Today? - Asianet Newsable
Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study - Investorideas.com
Edesa Biotech stock surges on positive Phase 3 trial data By Investing.com - Investing.com Canada
Edesa Biotech stock surges on positive Phase 3 trial data - Investing.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Edesa Biotech reports mortality reduction in phase 3 trial By Investing.com - Investing.com Australia
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results - TipRanks
Edesa Biotech reports mortality reduction in phase 3 trial - Investing.com
Edesa Biotech reports additional results from phase 3 paridiprubart study - marketscreener.com
Edesa Biotech shows significant 28-day mortality reduction in 278-patient Phase 3 study - TradingView
Mortality-cutting Phase 3 data boost Edesa Biotech (NASDAQ: EDSA) - Stock Titan
Edesa Biotech Reports Additional Results From Phase 3 Paridiprubart Study - TradingView
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewswire
Update Recap: Can Edesa Biotech Inc expand into new marketsMarket Trend Review & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Edesa Biotech reports FQ1 net loss of $2.2 million - MSN
Will Edesa Biotech Inc. stock benefit from infrastructure spending2025 Earnings Surprises & Accurate Technical Buy Alerts - mfd.ru
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Edesa Biotech, Inc. SEC 10-Q Report - TradingView
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - Bitget
Edesa Biotech (Nasdaq: EDSA) widens loss as R&D spending climbs - Stock Titan
Edesa Biotech, Inc. Reports Q1 2026 Financial Results and Updates on Clinical Programs for EB06 and Paridiprubart - Quiver Quantitative
Canada's Edesa Biotech Q1 net loss widens - TradingView
Can Edesa Biotech Inc. expand into new markets2025 Technical Patterns & Expert Verified Movement Alerts - mfd.ru
Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2025 - marketscreener.com
Gains Recap: Does Edesa Biotech Inc have pricing power2025 Historical Comparison & Risk Controlled Swing Alerts - baoquankhu1.vn
Bull Run: Does Edesa Biotech Inc have pricing powerBear Alert & Free Community Consensus Stock Picks - baoquankhu1.vn
Price Action: Is Edesa Biotech Incs growth already priced inJuly 2025 Technicals & Low Risk Growth Stock Ideas - baoquankhu1.vn
Fed Meeting: Can Edesa Biotech Inc sustain earnings growth2025 Top Decliners & Growth Focused Entry Point Reports - baoquankhu1.vn
Bearish Setup: Is PennantPark Investment Corporation a play on infrastructure spendingWeekly Trend Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Buy Signal: Can Edesa Biotech Inc expand into new marketsWeekly Gains Summary & Entry Point Strategy Guides - baoquankhu1.vn
Energy Moves: Is Edesa Biotech Incs growth already priced inJuly 2025 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
Does Edesa Biotech Inc stock benefit from AI growthEarnings Overview Report & Safe Entry Trade Reports - baoquankhu1.vn
Shorts Report: Will Edesa Biotech Inc stock gain from government policiesMarket Risk Analysis & Accurate Intraday Trade Tips - Bộ Nội Vụ
Is Edesa Biotech Inc. stock positioned for digital transformationShare Buyback & Stepwise Trade Execution Plans - Улправда
Why Edesa Biotech Inc. stock could be next big winnerDaily Trainer Picks & quick comparison of popular models - Улправда
Is Edesa Biotech Inc. stock vulnerable to regulatory risksMarket Performance Recap & Free Reliable Trade Execution Plans - Улправда
Edesa Biotech, Inc.Common Shares (NQ: EDSA - FinancialContent
Published on: 2026-01-06 14:04:13 - ulpravda.ru
Market Recap: How robust is Invesco Bloomberg Analyst Rating Improvers stock financial positionMarket Performance Recap & Long-Term Safe Investment Plans - moha.gov.vn
What is the fair value of Edesa Biotech Inc. stock nowForecast Cut & Community Trade Idea Sharing - Улправда
Is Edesa Biotech Inc. stock supported by strong fundamentals2025 AllTime Highs & Daily Technical Stock Forecast Reports - Улправда
Will Edesa Biotech Inc. stock recover faster than peersBond Market & Stepwise Swing Trade Plans - DonanımHaber
Diluted earnings per share (diluted EPS) of Edesa Biotech, Inc. – BOATS:EDSA - TradingView — Track All Markets
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):